Gaëtan Lesca

14.5k total citations
160 papers, 3.4k citations indexed

About

Gaëtan Lesca is a scholar working on Genetics, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Gaëtan Lesca has authored 160 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Genetics, 79 papers in Molecular Biology and 25 papers in Psychiatry and Mental health. Recurrent topics in Gaëtan Lesca's work include Genetics and Neurodevelopmental Disorders (60 papers), Genomics and Rare Diseases (34 papers) and Genomic variations and chromosomal abnormalities (26 papers). Gaëtan Lesca is often cited by papers focused on Genetics and Neurodevelopmental Disorders (60 papers), Genomics and Rare Diseases (34 papers) and Genomic variations and chromosomal abnormalities (26 papers). Gaëtan Lesca collaborates with scholars based in France, United States and Italy. Gaëtan Lesca's co-authors include Damien Sanlaville, Audrey Labalme, Patrick Edery, Vincent Cottin, Cyril Goizet, Nicole Baumann, M. T. Vanier, M. Sévin, Gilles Millat and F. Sedel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Gaëtan Lesca

139 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaëtan Lesca France 33 1.2k 1.0k 920 708 610 160 3.4k
Cyril Goizet France 35 1.7k 1.4× 539 0.5× 735 0.8× 481 0.7× 1.1k 1.8× 133 4.0k
David W. Stockton United States 32 3.3k 2.7× 1.3k 1.3× 413 0.4× 268 0.4× 1.3k 2.1× 70 4.9k
Katarzyna Kotulska Poland 33 1.2k 1.0× 617 0.6× 337 0.4× 284 0.4× 401 0.7× 135 3.8k
H. David Shine United States 30 1.5k 1.3× 1.0k 1.0× 516 0.6× 145 0.2× 1.2k 1.9× 50 3.7k
Alessandra Ferlini Italy 43 5.9k 4.8× 1.1k 1.1× 944 1.0× 224 0.3× 835 1.4× 233 7.1k
Dalil Hamroun France 24 2.1k 1.7× 976 0.9× 380 0.4× 330 0.5× 361 0.6× 60 3.5k
Salmo Raskin Brazil 28 1.5k 1.2× 578 0.6× 196 0.2× 332 0.5× 1.1k 1.8× 147 2.8k
Bert B.A. de Vries Netherlands 39 3.6k 3.0× 5.1k 4.9× 864 0.9× 721 1.0× 305 0.5× 114 7.4k
Patrick Edery France 33 2.4k 2.0× 1.6k 1.5× 221 0.2× 194 0.3× 304 0.5× 117 4.5k
Erik‐Jan Kamsteeg Netherlands 32 2.2k 1.8× 470 0.5× 206 0.2× 634 0.9× 704 1.2× 124 3.2k

Countries citing papers authored by Gaëtan Lesca

Since Specialization
Citations

This map shows the geographic impact of Gaëtan Lesca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaëtan Lesca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaëtan Lesca more than expected).

Fields of papers citing papers by Gaëtan Lesca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaëtan Lesca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaëtan Lesca. The network helps show where Gaëtan Lesca may publish in the future.

Co-authorship network of co-authors of Gaëtan Lesca

This figure shows the co-authorship network connecting the top 25 collaborators of Gaëtan Lesca. A scholar is included among the top collaborators of Gaëtan Lesca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaëtan Lesca. Gaëtan Lesca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aupy, Jérôme, Laurent Villard, Nathalie Villeneuve, et al.. (2025). GABRA2‐related encephalopathy: Identification of two phenotypes with distinctive electroclinical features. Epilepsia. 66(8).
2.
Schneider, Amy, Gaëtan Lesca, Joseph D. Symonds, et al.. (2025). SCN1A pathogenic variants do not have a distinctive blood‐derived DNA methylation signature. Epilepsia. 66(4). e66–e72.
3.
4.
5.
Mertens, Ann, et al.. (2024). Epilepsy with eyelid myoclonia in a patient with ATP1A3‐related neurologic disorder. Epileptic Disorders. 26(6). 847–852.
6.
Quēlin, Chloé, Laurent Pasquier, Philippe Loget, et al.. (2023). PHGDH-related microcephalic dwarfism in two fetuses: Expanding the phenotypical spectrum of L-serine biosynthesis defect. European Journal of Medical Genetics. 66(11). 104852–104852.
7.
Ragnarsson, Lotten, Zihan Zhang, Åsa Andersson, et al.. (2023). GRIN1 variants associated with neurodevelopmental disorders reveal channel gating pathomechanisms. Epilepsia. 64(12). 3377–3388. 5 indexed citations
8.
Jansen, Floor E., Charlotte W. Ockeloen, Marjan J. A. van Kempen, et al.. (2023). Epilepsy is an important feature of KBG syndrome associated with poorer developmental outcome. Epilepsia Open. 8(4). 1300–1313. 7 indexed citations
9.
Berecki, Géza, Katherine B. Howell, N.B. Olivier, et al.. (2022). Functional correlates of clinical phenotype and severity in recurrent SCN2A variants. Communications Biology. 5(1). 515–515. 21 indexed citations
10.
Pons, Linda, Tiffany Busa, Chantal Missirian, et al.. (2022). Disruption and deletion of the proximal part of TCF4 are associated with mild intellectual disability: About three new patients. European Journal of Medical Genetics. 65(4). 104458–104458. 3 indexed citations
11.
Jacquier, Arnaud, Fanny Fontaine, Nicolas Lacoste, et al.. (2022). Homozygous COQ7 mutation: a new cause of potentially treatable distal hereditary motor neuropathy. Brain. 146(8). 3470–3483. 11 indexed citations
12.
Patat, Olivier, Sandra Whalen, Lionel Arnaud, et al.. (2021). Patients with KCNH1 -related intellectual disability without distinctive features of Zimmermann-Laband/Temple-Baraitser syndrome. Journal of Medical Genetics. 59(5). 505–510. 8 indexed citations
13.
Schröter, Julian, Saskia Biskup, Kerstin Alexandra Klotz, et al.. (2021). Refining Genotypes and Phenotypes in KCNA2-Related Neurological Disorders. International Journal of Molecular Sciences. 22(6). 2824–2824. 25 indexed citations
14.
Soldovieri, Maria Virginia, Elena Freri, Paolo Ambrosino, et al.. (2020). Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy. Pharmacological Research. 160. 105200–105200. 13 indexed citations
15.
Poisson, Alice, Nicolas Chatron, Audrey Labalme, et al.. (2020). Chromatin remodeling dysfunction extends the etiological spectrum of schizophrenia: a case report. BMC Medical Genetics. 21(1). 10–10. 10 indexed citations
16.
Mazzola, Laure, Karen Oliver, Audrey Labalme, et al.. (2020). Progressive Myoclonus Epilepsy Caused by a Homozygous Splicing Variant of SLC7A6OS. Annals of Neurology. 89(2). 402–407. 2 indexed citations
17.
Pons, Linda, Audrey Labalme, Marianne Till, et al.. (2014). A new syndrome of intellectual disability with dysmorphism due to TBL1XR1 deletion. American Journal of Medical Genetics Part A. 167(1). 164–168. 35 indexed citations
18.
Rivière, Jean‐Baptiste, Masoud Shekarabi, Janet Laganière, et al.. (2011). Transit Defect of Potassium-Chloride Co-transporter 3 Is a Major Pathogenic Mechanism in Hereditary Motor and Sensory Neuropathy with Agenesis of the Corpus Callosum. Journal of Biological Chemistry. 286(32). 28456–28465. 20 indexed citations
19.
Lesca, Gaëtan, Virginie Bernard, Muriel Bozon, et al.. (2007). Mutation screening of the MECP2 gene in a large cohort of 613 fragile-X negative patients with mental retardation. European Journal of Medical Genetics. 50(3). 200–208. 5 indexed citations
20.
Philippe, Christophe, Laurent Villard, Nicolás de Roux, et al.. (2005). Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update. European Journal of Medical Genetics. 49(1). 9–18. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cyril Goizet Breakdown of academic impact, for papers by David W. Stockton Breakdown of academic impact, for papers by Katarzyna Kotulska Breakdown of academic impact, for papers by H. David Shine Breakdown of academic impact, for papers by Alessandra Ferlini Breakdown of academic impact, for papers by Dalil Hamroun Breakdown of academic impact, for papers by Salmo Raskin Breakdown of academic impact, for papers by Bert B.A. de Vries Breakdown of academic impact, for papers by Patrick Edery Breakdown of academic impact, for papers by Erik‐Jan Kamsteeg
Rankless by CCL
2026